Gregory Grabowski, MD, Professor Emeritus at University of Cincinnati College of Medicine highlights the latest research about Gaucher disease presented at WORLDSymposium 2022. This free CME program provides expert analysis on the clinical relevance of this research for the care team and help them care for the patients they may encounter with this rare condition. 

Gaucher disease is a genetic lysosomal storage disorder in which glucocerebroside accumulates in cells and certain organs. The disorder is characterized by bruising, fatigue, anemia, low blood platelet count and enlargement of the liver and spleen. Current therapies options include enzyme replace therapy or substrate reduction therapy but newer treatment options are in development. Furthermore, there is a genetic link between Gaucher disease and Parkinson’s disease that is currently being investigated. 

To access this free CME program, learn more about Gaucher disease, and improve the way you interact with your patients with this rare condition, visit 

Supported by an educational grant from Takeda Pharmaceuticals U.S.A. Inc.